EUVIMEDEUVIMED entdecken
Crossref

Plasma Proteomic Profiling of Comorbid and Noncomorbid COVID-19 Patients in ICU

Sara Taleb, Nisha Stephan iD, Praveen Babu Vemulapalli iD, Karsen Suhre iD, Ali Ait Hssain, Frank Schmidt, Sunkyu Choi iD

Journal of Proteome Research · 2026

DOI: 10.1021/acs.jproteome.6c00467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Sara Taleb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Core, Research, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, PO 24144, Doha, Qatar. Hauptthemen laut MEDLINE: COVID-19, Proteomics, Diabetes Mellitus, Type 2, Hypertension. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Hamad Medical Corporation, Weill Cornell Medicine - Qatar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 Diabetes (T2D) and hypertension (HTN) are common comorbidities in severe COVID-19, yet their specific impact on proteomic recovery remains unclear. This study analyzed plasma protein signatures of critical COVID-19 patients with and without these comorbidities (COVID-only group [COG] and COVID comorbid group [CTHG]) on the first and last days of ICU stay. Proteomic analysis revealed a systemic shift characterized by upregulated immune responses and downregulated metabolic processes at admission across all patients. Survival was fundamentally defined by the restoration of homeostasis; liver-derived proteins─including LPA, TTR, and AHSG─were initially suppressed but rebounded significantly in survivors. This homeostatic recovery was impaired in CTHG compared to COG, with CTHG survivors showing attenuated recovery of metabolic markers. Distinct mortality-associated signatures also emerged between groups. COG nonsurvivors exhibited liver failure and severe hemolysis marked by persistent suppression of haptoglobin (HP). In contrast, CTHG mortality was driven by lipid metabolism dysregulation, with CD5L and APOA2 levels dropping specifically in comorbid nonsurvivors, often accompanied by a paradoxical elevation in APOA4─likely reflecting impaired renal clearance rather than restored lipid homeostasis. These findings indicate that preexisting T2D and HTN hinder physiological resolution of metabolic and lipid dysregulation, providing proteomic evidence for distinct mortality risks associated with failure to restore metabolic homeostasis in comorbid COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ProteomicsDiabetes Mellitus, Type 2HypertensionBlood ProteinsProteomeHumansIntensive Care UnitsComorbidityFemaleMaleMiddle AgedSARS-CoV-2BiomarkersHaptoglobins

Stichwörter der Autor:innen

COVID-19DIA-MSICUcomorbiditymass spectrometryplasmaproteomics

Substanzen

Blood ProteinsProteomeBiomarkersHaptoglobins

Autor:innen und Institutionen

  • Proteomics Core, Research, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, PO 24144, Doha, Qatar.
  • Bioinformatics Core, Research, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, PO 24144, Doha, Qatar.
  • Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.

ORCID-Profile: Nisha Stephan, Praveen Babu Vemulapalli, Karsen Suhre, Sunkyu Choi

Förderung

  • Hamad Medical Corporation
  • Weill Cornell Medicine - Qatar

Zitieren

APA

Taleb, S., Stephan, N., Vemulapalli, P. B., Suhre, K., Hssain, A. A., Schmidt, F., & Choi, S. (2026). Plasma Proteomic Profiling of Comorbid and Noncomorbid COVID-19 Patients in ICU. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6c00467

Vancouver

Taleb S, Stephan N, Vemulapalli PB, Suhre K, Hssain AA, Schmidt F, et al. Plasma Proteomic Profiling of Comorbid and Noncomorbid COVID-19 Patients in ICU. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.6c00467

BibTeX
@article{Taleb2026,
  author = {Taleb, Sara and Stephan, Nisha and Vemulapalli, Praveen Babu and Suhre, Karsen and Hssain, Ali Ait and Schmidt, Frank and Choi, Sunkyu},
  title = {Plasma Proteomic Profiling of Comorbid and Noncomorbid COVID-19 Patients in ICU},
  journal = {Journal of Proteome Research},
  year = {2026},
  doi = {10.1021/acs.jproteome.6c00467}
}
Kostenlos starten →